A Study to Evaluate the Safety and Immunogenicity of Inactivated Varicella Zoster Virus (VZV) Vaccine in Adults With Autoimmune Disease (V212-009)
Clinical trial NCT01527383 · COMPLETED
Trial details
- NCT number
- NCT01527383
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-21
- Primary completion
- 2013-02-26
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.